You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Sotorasib in KRASG12C mutated lung cancer: Can we rule out cracking KRAS led to worse overall survival?
|
|---|---|
| Published in |
Translational Oncology, December 2022
|
| DOI | 10.1016/j.tranon.2022.101591 |
| Pubmed ID | |
| Authors |
Timothée Olivier, Alyson Haslam, Vinay Prasad |
X Demographics
The data shown below were collected from the profiles of 64 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 9% |
| Spain | 3 | 5% |
| India | 3 | 5% |
| Georgia | 1 | 2% |
| Malaysia | 1 | 2% |
| Italy | 1 | 2% |
| France | 1 | 2% |
| Austria | 1 | 2% |
| Côte d'Ivoire | 1 | 2% |
| Other | 5 | 8% |
| Unknown | 41 | 64% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 51 | 80% |
| Practitioners (doctors, other healthcare professionals) | 7 | 11% |
| Scientists | 6 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 17 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Doctoral Student | 3 | 18% |
| Student > Ph. D. Student | 2 | 12% |
| Researcher | 2 | 12% |
| Lecturer > Senior Lecturer | 1 | 6% |
| Unknown | 9 | 53% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 4 | 24% |
| Biochemistry, Genetics and Molecular Biology | 3 | 18% |
| Earth and Planetary Sciences | 1 | 6% |
| Unknown | 9 | 53% |
Attention Score in Context
This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2024.
All research outputs
#1,075,925
of 25,838,141 outputs
Outputs from Translational Oncology
#16
of 1,223 outputs
Outputs of similar age
#23,632
of 482,800 outputs
Outputs of similar age from Translational Oncology
#1
of 28 outputs
Altmetric has tracked 25,838,141 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,223 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 482,800 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.